Diabetic Macular Oedema Clinical Trial
Official title:
Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular Oedema (DMO)- Randomized Controlled Trial
Diabetic macular oedema (DMO) is a sight-threatening problem for diabetic patient who has
swelling in macula. Patients with DMO can receive laser treatment and achieve good acuity
finally. However, some patients still have difficulties in reading even after proper
treatment.
In this project, the investigators aimed to explore the effectiveness of different training
paradigms in improving reading performance in patients with DMO.
Patients with diabetic macular oedema (DMO), after receiving laser photocoagulation, achieved
good outcomes in distance acuity. However, some patients, particularly those developing
parafoveal scotoma, still had difficulty in reading. Inability to read or reading very slowly
leads to the potential loss of job, as well as the enjoyment of reading for leisure.
In this study, the investigators aimed to investigate the effectiveness of reading
rehabilitation using perceptual learning paradigms in enhancing reading performance in
patients with reading difficulties due to DMO. Also, the fundamental mechanisms explaining
the reading problems in patients with DMO reading Chinese will be examined.
The investigators hypothesize that the perceptual training would show an improvement in
reading. The investigators' primary hypothesis is that temporal visual processing speed and
spatial visual span will be improved after perceptual training. The investigators' secondary
hypothesis is that the reading speed and fixation stability will be improved after training.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04576689 -
Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - A Sustained, Low Dose Dexamethasone Therapy
|
Phase 2 | |
| Completed |
NCT02554747 -
Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa
|
N/A | |
| Withdrawn |
NCT02309476 -
Sub-threshold Photocoagulation of Diabetic Macular Oedema
|
N/A | |
| Terminated |
NCT02207712 -
Noctura400 Treatment for Diabetic Retinopathy (CANDLE)
|
N/A | |
| Completed |
NCT00148330 -
Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study
|
Phase 2/Phase 3 | |
| Completed |
NCT03495765 -
To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT00167518 -
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO)
|
Phase 2/Phase 3 | |
| Completed |
NCT01787669 -
Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
|
Phase 2 | |
| Completed |
NCT01175070 -
Intravitreal Macugen for Ischaemic Diabetic Macular Oedema
|
Phase 4 | |
| Terminated |
NCT00427986 -
Clinical Study of the Effect of Intravenous Galactose on Diabetic Macular Oedema
|
N/A | |
| Completed |
NCT00333671 -
Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema)
|
N/A | |
| Completed |
NCT02731911 -
Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study
|
||
| Completed |
NCT00148265 -
A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema
|
Phase 2/Phase 3 | |
| Completed |
NCT02181400 -
Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema
|
N/A |